Drug‐Induced Liver Injury in Patients With Chronic Liver Disease
Liver International · 2025-03 · 45 (3)
DOI: 10.1111/liv.70019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Liver International, online erschienen am 10.02.2025. Verfasst von Marwan Ghabril und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Liver Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Drug‐induced liver injury (DILI) is a global problem and can develop from exposure to prescription or over‐the‐counter medications as well as herbal and dietary supplements. The diagnosis of DILI is clinically challenging, and liver injury can be severe leading to liver failure, death, or liver transplantation. Patients with underlying chronic liver diseases (CLD) may be at increased risk for DILI, which is associated with factors related to drug or liver disease.
Methods
This review summarises current knowledge on the risk and outcomes of DILI in patients with CLD.
Results
Patients with CLD may be at an increased risk for DILI. Additionally patients with underlying CLD are at risk for more severe liver injury and worse outcomes after DILI.
Discussion
The risk for and poor outcomes from DILI are accentuated in patients with CLD and potentially leading to the worst‐case scenario of acute‐on‐chronic liver failure. We highlight the key observations on DILI with a broad range of underlying liver diseases and the high‐DILI risk agents implicated in those populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology and Hepatology, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA.
ORCID-Profile: Marwan Ghabril
Zitieren
APA
Ghabril, M., Vuppalanchi, R., & Chalasani, N. (2025). Drug‐Induced Liver Injury in Patients With Chronic Liver Disease. Liver International, 45(3). https://doi.org/10.1111/liv.70019
Vancouver
Ghabril M, Vuppalanchi R, Chalasani N. Drug‐Induced Liver Injury in Patients With Chronic Liver Disease. Liver International. 2025;45(3). doi:10.1111/liv.70019
BibTeX
@article{Ghabril2025,
author = {Ghabril, Marwan and Vuppalanchi, Raj and Chalasani, Naga},
title = {Drug‐Induced Liver Injury in Patients With Chronic Liver Disease},
journal = {Liver International},
year = {2025},
volume = {45},
number = {3},
doi = {10.1111/liv.70019}
}
EUVIMED